Multiple growth factor signaling, including epithelial growth factor (EGF), and insulin-like growth factor (IGF) could interfere with PR signaling and regulate its expression (33), indicating that ER-negative/PR-positive is a distinct entity and proved to be morphologically and molecularly close to triple-negative breast cancer. The gene discussed is PGR; the disease is triple-negative breast carcinoma.